跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIMPAT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VIMPAT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
VIMPAT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 8, 2024
Approval ID
3e345d435c36dbc9
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
3e345d435c36dbc9
Drug Cima Aemps Name
VIMPAT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
08470011IP
Holder Company Name
Ucb Pharma
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/ucb-pharma-sa
Authorization Date
2024-03-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
200 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Active Ingredients
LACOSAMIDA
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 8, 2024
Approval ID
3e345d435c36dbc9
Type
Standard
Back to CIMA-AEMPS Approvals
